Published in

American Society for Pharmacology and Experimental Therapeutics (ASPET), Drug Metabolism and Disposition, 9(48), p. 769-777, 2020

DOI: 10.1124/dmd.120.090928

Links

Tools

Export citation

Search in Google Scholar

Drug–drug interaction risk assessment of esaxerenone as a perpetrator by in vitro studies, and static and physiologically based pharmacokinetic models

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO